Foodborne botulism outbreak with potential new management options.

IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Ali H Altalag, Mohammed A Badawee, Sahar A Hassan, Nahla A Habiballa, Naif M Alotaibi, Ehab A Ahmed, Mohammed N Aljuaid, Muhammad A Almalki, Ahmed A Alahmari, Adulrahman A Alshehri
{"title":"Foodborne botulism outbreak with potential new management options.","authors":"Ali H Altalag, Mohammed A Badawee, Sahar A Hassan, Nahla A Habiballa, Naif M Alotaibi, Ehab A Ahmed, Mohammed N Aljuaid, Muhammad A Almalki, Ahmed A Alahmari, Adulrahman A Alshehri","doi":"10.15537/smj.2024.45.6.20240419","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To shed some light on a potential therapeutic modality that may facilitate resolution of botulism symptoms, namely 3,4-diaminopyridine (3,4-DAP).</p><p><strong>Methods: </strong>In Riyadh, Saudi Arabia, we recently encountered a foodborne botulism outbreak that, luckily, was discovered early. In Prince Sultan Military Medical city, we admitted, during a period of approximately 3 weeks, 15 probable cases, 2 of which were excluded due to more likely alternative diagnoses. We report in this case series 13 highly suspected cases of botulism that we encountered during the outbreak.</p><p><strong>Results: </strong>A total of 12 out of 13 patients required intensive care unit (ICU) admission, one of which required intubation. Symptoms included cranial nerve palsies, gastrointestinal symptoms, limb and respiratory muscle weakness. Patients showed clinical improvement when received botulinum antitoxin and 3,4-DAP if given early in the course of the disease.</p><p><strong>Conclusion: </strong>Early admisntration of 3,4-DAP may facilitate recovery and prevent disease progression. Larger prospective trials should be carried out to confirm that.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147606/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15537/smj.2024.45.6.20240419","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To shed some light on a potential therapeutic modality that may facilitate resolution of botulism symptoms, namely 3,4-diaminopyridine (3,4-DAP).

Methods: In Riyadh, Saudi Arabia, we recently encountered a foodborne botulism outbreak that, luckily, was discovered early. In Prince Sultan Military Medical city, we admitted, during a period of approximately 3 weeks, 15 probable cases, 2 of which were excluded due to more likely alternative diagnoses. We report in this case series 13 highly suspected cases of botulism that we encountered during the outbreak.

Results: A total of 12 out of 13 patients required intensive care unit (ICU) admission, one of which required intubation. Symptoms included cranial nerve palsies, gastrointestinal symptoms, limb and respiratory muscle weakness. Patients showed clinical improvement when received botulinum antitoxin and 3,4-DAP if given early in the course of the disease.

Conclusion: Early admisntration of 3,4-DAP may facilitate recovery and prevent disease progression. Larger prospective trials should be carried out to confirm that.

食源性肉毒杆菌爆发,可能出现新的管理方案。
目的方法:我们最近在沙特阿拉伯利雅得遇到了一起食源性肉毒中毒疫情,幸好发现得早:方法:沙特阿拉伯利雅得最近爆发了一起食源性肉毒中毒事件,所幸发现得早。在苏尔坦亲王军事医疗城,我们在大约 3 周的时间内收治了 15 例疑似病例,其中 2 例因有更可能的替代诊断而被排除。我们在本病例系列中报告了疫情爆发期间遇到的 13 例高度疑似肉毒中毒病例:结果:13 名患者中共有 12 人需要入住重症监护室(ICU),其中一人需要插管。症状包括颅神经麻痹、胃肠道症状、四肢和呼吸肌无力。如果在病程早期使用肉毒杆菌抗毒素和 3,4-DAP,患者的临床症状会有所改善:结论:早期服用 3,4-DAP可促进康复并防止病情恶化。应进行更大规模的前瞻性试验来证实这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Saudi Medical Journal
Saudi Medical Journal 医学-医学:内科
CiteScore
2.30
自引率
6.20%
发文量
203
审稿时长
12 months
期刊介绍: The Saudi Medical Journal is a monthly peer-reviewed medical journal. It is an open access journal, with content released under a Creative Commons attribution-noncommercial license. The journal publishes original research articles, review articles, Systematic Reviews, Case Reports, Brief Communication, Brief Report, Clinical Note, Clinical Image, Editorials, Book Reviews, Correspondence, and Student Corner.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信